Prospect Financial Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Prospect Financial Group's NVS Position: Q3 2026 in Review
Prospect Financial Group reduced its Novartis (NVS) stake by 21% in Q3 2026, selling an estimated $70.7K and leaving 1,709 shares worth $244K. The position accounts for 0.2% of the portfolio, ranked #54.
Prospect Financial Group first reported a position in NVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $341K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Prospect Financial Group held 1,709 shares of Novartis worth $244K as of Q3 2026.
- Prospect Financial Group sold 466 Novartis shares in Q3 2026, an estimated $70.7K.
- Novartis made up 0.2% of Prospect Financial Group's portfolio in Q3 2026, its #54 holding.
- Prospect Financial Group first reported a position in Novartis in Q4 2024 and has held it in 8 quarters since.
- Prospect Financial Group's Novartis position peaked at $341K in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Prospect Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.